Purchase Order 75N93023P00987

Award Date 7/25/23
Potential Completion Date 7/24/24
Potential Value $14K
Ultimate Awardee
Revvity Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Shelton, CT 06484, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded an $11,340 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver one S/N IS1831N7468 IVIS Lumina LT instrument, Series III, 120V, along with a Bronze Service Plan and model INVCLS136331. The contract has a period of performance from June 25, 2023 through June 24, 2024. Place of performance will be in Shelton,...
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a firm fixed-price purchase order valued at thirteen thousand three hundred thirty-five dollars by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The contract is for a gold service plan with one preventative maintenance for a Cellaca MX device with AOPI configuration bundle and serial number MX-120-0261. The period of performance is one...
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a firm fixed price purchase order valued at fourteen thousand six hundred fifteen dollars ($14,615) by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract calls for Revvity Health Sciences to provide ALPHALISA HIV P24 (HS) KITS (AMBIS #2184099) with performance taking place in Shelton, Connecticut over the...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $99,222.50 firm fixed-price purchase order to Revvity Health Sciences, Inc. for a pathology imaging system. This contract, which does not have a set-aside designation, was completed on July 31, 2018. Revvity Health Sciences, Inc. is a subsidiary of the larger Revvity Inc. organization, which operates a Medical Imaging division that provides...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Revvity Health Sciences, Inc., a for-profit manufacturer, for the purchase of an IVIS Lumina LT, Series III, 120V imaging system and related equipment. The total potential value of the award is $121,130.00. This contract did not utilize any set-aside designations. Revvity Health Sciences, Inc. is an experienced provider of...
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $15,771 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide an annual service agreement for a Celigo microplate reader. The place of performance will be in Bethesda, Maryland. The period of performance is from December 28, 2023 through December 27, 2024. No subcontractors or set aside designations were indicated....
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $14,940.06 firm fixed-price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver a CELLOMETER AUTO 2000 BUNDLE (AMBIS #2185560). Performance will occur in Shelton, Connecticut over a six-month period concluding in March 2024. No subcontractors or set-aside designations were indicated. This...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price purchase order contract to Revvity Health Sciences, Inc. for $5,472.00. The contract is for the provision of medical imaging products and services, with a period of performance from September 15, 2017 to September 17, 2018. This contract was not set aside for any small business category. Revvity Health Sciences, Inc. is a for-profit...
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $11,007.96 firm fixed-price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide an annual Gold Service Plan with one preventative maintenance for an Envision Xcite medical device. The contract carries a one-year period of performance from February 1, 2024 through January 31, 2025. Place of performance will be in Hopkinton,...
This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. for $5,308.00 in onsite support services. The contract has a period of performance through August 1, 2015. No set-aside was used for this award. Revvity Health Sciences, Inc. is a for-profit medical imaging company that provides laboratory equipment, maintenance services, and...

Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $13,560 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide a non-NIH networked computer to operate laboratory instruments. The computer will support research at the agency's facilities in Shelton, Connecticut under a one-year period of performance through July 2024. No subcontractors or set aside designations were specified. This purchase augments the NIH's efforts to understand and treat allergic, infectious and immunological diseases through laboratory research and testing.

Generated 12/24/23, 9:40 PM